Antibodies in cancer treatment-II

Editorial

B Desoize. Crit Rev Oncol Hematol. 2007 Dec.

. 2007 Dec;64(3):208-9.

doi: 10.1016/j.critrevonc.2007.09.005.

No abstract available

Comment on

Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment.
Magdelaine-Beuzelin C, Kaas Q, Wehbi V, Ohresser M, Jefferis R, Lefranc MP, Watier H. Magdelaine-Beuzelin C, et al. Crit Rev Oncol Hematol. 2007 Dec;64(3):210-25. doi: 10.1016/j.critrevonc.2007.04.011. Epub 2007 Jul 12. Crit Rev Oncol Hematol. 2007. PMID: 17624800 Review.
Recombinant therapeutic monoclonal antibodies: mechanisms of action in relation to structural and functional duality.
Congy-Jolivet N, Probst A, Watier H, Thibault G. Congy-Jolivet N, et al. Crit Rev Oncol Hematol. 2007 Dec;64(3):226-33. doi: 10.1016/j.critrevonc.2007.06.013. Epub 2007 Aug 22. Crit Rev Oncol Hematol. 2007. PMID: 17716905 Review.